Aprogen Biologics Inc. (KRX:003060)
South Korea
· Delayed Price · Currency is KRW 251.00
+12.00 (5.02%)
Apr 14, 2026, 7:45 AM KST
Aprogen Biologics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 24,393 | 12,306 | 10,053 | 23,609 | 35,074 | Upgrade
|
| Short-Term Investments | - | - | - | 390 | 75,000 | Upgrade
|
| Trading Asset Securities | 27,240 | 26,013 | - | 75,075 | 14,861 | Upgrade
|
| Cash & Short-Term Investments | 51,633 | 38,319 | 10,053 | 99,074 | 124,935 | Upgrade
|
| Cash Growth | 34.75% | 281.15% | -89.85% | -20.70% | -39.08% | Upgrade
|
| Accounts Receivable | 15,663 | 16,607 | 14,807 | 17,769 | 12,825 | Upgrade
|
| Other Receivables | 5,344 | 1,682 | 1,828 | 4,256 | 8,259 | Upgrade
|
| Receivables | 47,930 | 22,972 | 23,373 | 82,060 | 215,755 | Upgrade
|
| Inventory | 51,601 | 52,286 | 48,128 | 52,313 | 10,420 | Upgrade
|
| Prepaid Expenses | 726.67 | 895.05 | 2,490 | 558.14 | 10.67 | Upgrade
|
| Other Current Assets | 2,638 | 729.2 | 812.78 | 6,604 | 2,354 | Upgrade
|
| Total Current Assets | 154,529 | 115,200 | 84,857 | 240,608 | 353,474 | Upgrade
|
| Property, Plant & Equipment | 322,533 | 321,458 | 318,212 | 323,773 | 18,857 | Upgrade
|
| Long-Term Investments | 38,920 | 91,994 | 137,647 | 57,793 | 84,232 | Upgrade
|
| Other Intangible Assets | 5,277 | 5,116 | 6,241 | 6,458 | 2,796 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | - | 20,577 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 662.84 | 755.7 | Upgrade
|
| Other Long-Term Assets | 24,936 | 3,676 | 3,793 | 10,099 | 9,229 | Upgrade
|
| Total Assets | 586,993 | 590,984 | 589,397 | 684,140 | 614,621 | Upgrade
|
| Accounts Payable | 3,073 | 1,996 | 1,333 | 3,809 | 652.59 | Upgrade
|
| Accrued Expenses | 5,000 | 3,756 | 3,747 | 4,968 | 1,201 | Upgrade
|
| Short-Term Debt | 167,612 | 103,630 | 129,360 | 134,263 | 2,162 | Upgrade
|
| Current Portion of Leases | 2,509 | 2,191 | 1,360 | 345.5 | 199.49 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 4.18 | 273.93 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 119.99 | Upgrade
|
| Other Current Liabilities | 50,939 | 35,936 | 22,138 | 17,716 | 4,840 | Upgrade
|
| Total Current Liabilities | 229,133 | 147,509 | 157,938 | 161,106 | 9,449 | Upgrade
|
| Long-Term Debt | 40,000 | 32,000 | 32,000 | - | - | Upgrade
|
| Long-Term Leases | 18,675 | 16,197 | 18,277 | 129.06 | 120 | Upgrade
|
| Pension & Post-Retirement Benefits | 10,506 | 10,245 | 7,732 | 7,564 | 5,600 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 5,601 | 3,874 | 2,932 | 3,108 | 1,093 | Upgrade
|
| Other Long-Term Liabilities | 5,510 | 2,470 | 1,827 | 1,823 | 1,178 | Upgrade
|
| Total Liabilities | 309,426 | 212,294 | 220,705 | 173,730 | 17,440 | Upgrade
|
| Common Stock | 99,204 | 99,204 | 332,877 | 292,877 | 199,288 | Upgrade
|
| Additional Paid-In Capital | 704,331 | 704,331 | 358,030 | 335,850 | 327,715 | Upgrade
|
| Retained Earnings | -409,280 | -239,199 | -133,310 | -8,085 | -21,115 | Upgrade
|
| Treasury Stock | -4,485 | -4,485 | -4,463 | -41.27 | -41.27 | Upgrade
|
| Comprehensive Income & Other | -182,014 | -181,360 | -184,443 | -194,079 | 2,092 | Upgrade
|
| Total Common Equity | 207,757 | 378,491 | 368,691 | 426,521 | 507,939 | Upgrade
|
| Minority Interest | 69,810 | 199.28 | - | 83,890 | 89,242 | Upgrade
|
| Shareholders' Equity | 277,567 | 378,691 | 368,691 | 510,411 | 597,181 | Upgrade
|
| Total Liabilities & Equity | 586,993 | 590,984 | 589,397 | 684,140 | 614,621 | Upgrade
|
| Total Debt | 228,796 | 154,017 | 180,997 | 134,738 | 2,481 | Upgrade
|
| Net Cash (Debt) | -177,163 | -115,698 | -170,944 | -35,664 | 122,454 | Upgrade
|
| Net Cash Growth | - | - | - | - | -39.41% | Upgrade
|
| Net Cash Per Share | -13448.64 | -13803.94 | -40646.99 | -13234.78 | 46085.02 | Upgrade
|
| Filing Date Shares Outstanding | 13.18 | 13.17 | 4.38 | 3.9 | 2.66 | Upgrade
|
| Total Common Shares Outstanding | 13.18 | 13.17 | 4.38 | 3.9 | 2.66 | Upgrade
|
| Working Capital | -74,604 | -32,308 | -73,081 | 79,502 | 344,025 | Upgrade
|
| Book Value Per Share | 15764.78 | 28735.58 | 84108.18 | 109224.47 | 191160.18 | Upgrade
|
| Tangible Book Value | 202,480 | 373,376 | 362,451 | 420,063 | 505,142 | Upgrade
|
| Tangible Book Value Per Share | 15364.37 | 28347.19 | 82684.48 | 107570.66 | 190107.77 | Upgrade
|
| Land | 38,461 | 29,664 | 25,156 | 28,315 | 9,313 | Upgrade
|
| Buildings | 102,328 | 97,599 | 97,507 | 101,378 | 9,647 | Upgrade
|
| Machinery | 225,657 | 179,320 | 118,620 | 145,738 | 10,258 | Upgrade
|
| Construction In Progress | 30,975 | 64,463 | 108,996 | 90,433 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.